Global Infertility Diagnosis and Treatment Market Research and Analysis, 2015-2021
The Global infertility diagnosis and treatment market is expected to grow at CAGR of 6.3% from 2016 to 2021. In Vitro fertilization (IVF) is the largest segment of infertility diagnosis and treatment market and expected to be the largest segment in the year 2021 however Semen Analysis is the fastest growing segment of infertility diagnosis and treatment market with expected CAGR of XX% from 2016-2021. Lifestyle factors such as smoking, stress, weight and also the Female age factor (age above 35 years) are reason behind infertility.
The Global infertility diagnosis and treatment market is broadly categorized in two segments Male and female infertility. Male and female infertility market further divided in two major category Infertility Diagnosis and treatment market. North America (U.S.A. and Canada), Europe (Western Europe and rest of Europe), APAC (India, China and Japan) are major geographies which included in this report. North America is the largest market for the infertility diagnosis and treatment however APAC is the fastest growing market of infertility diagnosis and treatment with CAGR of xx% from 2016 to 2020.
Competitive landscape incudes market share analysis, Key company Analysis, Key strategies and corporate profiling. Companies profiled in the report are Bayer Ag, Bristol-Myers Squibb Co, Church & Dwight Company Inc., Cook Medical Inc., Coopersurgical Inc, Eli Lilly & Co., Emd Serono Inc, Endo Pharmaceuticals Inc, Ferring Pharmaceuticals, Genea, Glaxosmithkline Plc, Halotech Dna, Irvine Scientific, Janssen Pharmaceutical, Merck Serono, Novartis International Ag, Origio, Ovascience, Pfizer Inc, Princeton Biomeditech Corp, Progyny, Quidel Corp, Vitrolife Ab and Vivus Inc.
The Global infertility diagnosis and treatment market is broadly categorized in two segments Male and female infertility. Male and female infertility market further divided in two major category Infertility Diagnosis and treatment market. North America (U.S.A. and Canada), Europe (Western Europe and rest of Europe), APAC (India, China and Japan) are major geographies which included in this report. North America is the largest market for the infertility diagnosis and treatment however APAC is the fastest growing market of infertility diagnosis and treatment with CAGR of xx% from 2016 to 2020.
Competitive landscape incudes market share analysis, Key company Analysis, Key strategies and corporate profiling. Companies profiled in the report are Bayer Ag, Bristol-Myers Squibb Co, Church & Dwight Company Inc., Cook Medical Inc., Coopersurgical Inc, Eli Lilly & Co., Emd Serono Inc, Endo Pharmaceuticals Inc, Ferring Pharmaceuticals, Genea, Glaxosmithkline Plc, Halotech Dna, Irvine Scientific, Janssen Pharmaceutical, Merck Serono, Novartis International Ag, Origio, Ovascience, Pfizer Inc, Princeton Biomeditech Corp, Progyny, Quidel Corp, Vitrolife Ab and Vivus Inc.
REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. SEGMENTATION BY DIAGNOSIS
1.2.2. BY TREATMENT
1.2.3. BY GEOGRAPHY
1.2.4. BY STAKEHOLDERS
1.2.5. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. UNITED STATES
2.6.2. EUROPEAN UNION
2.6.3. CHINA
2.6.4. INDIA
2.6.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. LIFESTYLE FACTOR SUCH AS SMOKING, STRESS AND WEIGHT
3.1.2. FEMALE AGE FACTOR (AGE ABOVE 35 YEARS)
3.1.3. ERECTILE DYSFUNCTION IS ANOTHER FACTOR DRIVING MALE INFERTILITY TREATMENT MARKET
3.1.4. INCREASED SUCCESS RATE OF IVF TREATMENT IS DRIVING THE MARKET
3.1.5. HIGH PREVALENCE RATE IN MALE AND FEMALE BOTH
3.1.6. THE MARKET IS MOTIVATED BY DONOR EGG AND SPERM
3.1.7. SURROGACY IS ANOTHER DRIVING FACTOR OF THE MARKET
3.1.8. JOINT VENTURE AND COLLABORATION TO PROVIDE PROPER MEDICAL CARE
3.1.9. NEW TECHNOLOGIES TO AVOID MULTIPLE EMBRYO IMPLANTS
3.1.10. SURROGACY IS LEGAL IN SOME GEOGRAPHIES
3.2. RESTRAINT
3.2.1. COST STRUCTURE IS A RESTRAINT FOR THE MARKET
3.2.2. LACK OF INFRASTRUCTURE IN DEVELOPING COUNTRIES
3.2.3. REIMBURSEMENT POLICIES IN VARIOUS GEOGRAPHIES ARE RESTRAINING THE MARKET
3.3. OPPORTUNITY
3.3.1. EMERGING MARKET SUCH AS INDIA AND CHINA ARE MOST OPPORTUNITY MARKETS
3.3.2. MEDICAL TOURISM IN DEVELOPING COUNTRIES
MARKET SEGMENTATION
4.1. GLOBAL INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1. MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.1. SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.2. GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.3. TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.4. HORMONE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.5. OTHER TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2. FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.1. OVULATION TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.2. HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.3. HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.4. IMAGING TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.5. OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.6. HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.7. GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.8. OTHERS TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2. GLOBAL INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1. MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.1. DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.2. SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.3. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.4. OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2. FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.1. DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.2. SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.3. INTRAUTERINE INSEMINATION (IUI) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.1. IN VITRO FERTILIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.2. INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.3. ASSISTED HATCHING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.5. OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
5.3. KEY STRATEGIES ANALYSIS
5.3.1. PARTNERSHIP AND COLLABORATION
5.3.2. PRODUCT LAUNCHES AND NEW PRODUCT DEVELOPMENTS
5.3.3. MERGER AND ACQUISITION
5.3.4. PATENT AND LICENSES
5.3.5. OTHER STRATEGIES
REGIONAL ANALYSIS
6.1. NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. BAYER AG
7.1.1. COMPANY OVERVIEW
7.1.2. BAYER AG PRODUCT PORTFOLIO
7.1.3. BAYER AG RECENT ACTIVITIES
7.1.4. BAYER AG SWOT ANALYSIS
7.2. BRISTOL-MYERS SQUIBB CO.
7.2.1. COMPANY OVERVIEW
7.2.2. BRISTOL-MYERS SQUIBB CO. PRODUCT PORTFOLIO
7.2.3. BRISTOL-MYERS SQUIBB CO. RECENT ACTIVITIES
7.2.4. BRISTOL-MYERS SQUIBB CO. SWOT ANALYSIS
7.3. CHURCH & DWIGHT COMPANY INC.
7.3.1. COMPANY OVERVIEW
7.3.2. CHURCH & DWIGHT COMPANY INC. PRODUCT PORTFOLIO
7.3.3. CHURCH & DWIGHT COMPANY INC. RECENT ACTIVITIES
7.3.4. CHURCH & DWIGHT COMPANY INC. SWOT ANALYSIS
7.4. COOK MEDICAL, INC.
7.4.1. COMPANY OVERVIEW
7.4.2. COOK MEDICAL, INC. PRODUCT PORTFOLIO
7.4.3. COOK MEDICAL, INC. RECENT ACTIVITIES
7.4.4. COOK MEDICAL, INC. SWOT ANALYSIS
7.5. COOPERSURGICAL INC.
7.5.1. COMPANY OVERVIEW
7.5.2. COOPERSURGICAL INC. PRODUCT PORTFOLIO
7.5.3. COOPERSURGICAL INC. RECENT ACTIVITIES
7.5.4. COOPERSURGICAL INC. SWOT ANALYSIS
7.6. ELI LILLY & CO.
7.6.1. COMPANY OVERVIEW
7.6.2. ELI LILLY & CO. PRODUCT PORTFOLIO
7.6.3. ELI LILLY & CO. RECENT ACTIVITIES
7.6.4. ELI LILLY & CO. SWOT ANALYSIS
7.7. EMD SERONO, INC
7.7.1. COMPANY OVERVIEW
7.7.2. EMD SERONO, INC PRODUCT PORTFOLIO
7.7.3. EMD SERONO, INC RECENT ACTIVITIES
7.7.4. EMD SERONO, INC SWOT ANALYSIS
7.8. ENDO PHARMACEUTICALS INC.
7.8.1. COMPANY OVERVIEW
7.8.2. ENDO PHARMACEUTICALS INC. PRODUCT PORTFOLIO
7.8.3. ENDO PHARMACEUTICALS INC. RECENT ACTIVITIES
7.8.4. ENDO PHARMACEUTICALS INC. SWOT ANALYSIS
7.9. FERRING PHARMACEUTICALS
7.9.1. COMPANY OVERVIEW
7.9.2. FERRING PHARMACEUTICALS PRODUCT PORTFOLIO
7.9.3. FERRING PHARMACEUTICALS RECENT ACTIVITIES
7.9.4. FERRING PHARMACEUTICALS SWOT ANALYSIS
7.10. GENEA
7.10.1. COMPANY OVERVIEW
7.10.2. GENEA PRODUCT PORTFOLIO
7.10.3. GENEA RECENT ACTIVITIES
7.10.4. GENEA SWOT ANALYSIS
7.11. GLAXOSMITHKLINE PLC
7.11.1. COMPANY OVERVIEW
7.11.2. GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
7.11.3. GLAXOSMITHKLINE PLC RECENT ACTIVITIES
7.11.4. GLAXOSMITHKLINE PLC SWOT ANALYSIS
7.12. HALOTECH DNA
7.12.1. COMPANY OVERVIEW
7.12.2. HALOTECH DNA PRODUCT PORTFOLIO
7.12.3. HALOTECH DNA RECENT ACTIVITIES
7.12.4. HALOTECH DNA SWOT ANALYSIS
7.13. IRVINE SCIENTIFIC
7.13.1. COMPANY OVERVIEW
7.13.2. IRVINE SCIENTIFIC PRODUCT PORTFOLIO
7.13.3. IRVINE SCIENTIFIC RECENT ACTIVITIES
7.13.4. IRVINE SCIENTIFIC SWOT ANALYSIS
7.14. JANSSEN PHARMACEUTICAL
7.14.1. COMPANY OVERVIEW
7.14.2. JANSSEN PHARMACEUTICAL PRODUCT PORTFOLIO
7.14.3. JANSSEN PHARMACEUTICAL RECENT ACTIVITIES
7.14.4. JANSSEN PHARMACEUTICAL SWOT ANALYSIS
7.15. MERCK SERONO
7.15.1. COMPANY OVERVIEW
7.15.2. MERCK SERONO PRODUCT PORTFOLIO
7.15.3. MERCK SERONO RECENT ACTIVITIES
7.15.4. MERCK SERONO SWOT ANALYSIS
7.16. NOVARTIS INTERNATIONAL AG
7.16.1. COMPANY OVERVIEW
7.16.2. NOVARTIS INTERNATIONAL AG PRODUCT PORTFOLIO
7.16.3. NOVARTIS INTERNATIONAL AG RECENT ACTIVITIES
7.16.4. NOVARTIS INTERNATIONAL AG SWOT ANALYSIS
7.17. ORIGIO
7.17.1. COMPANY OVERVIEW
7.17.2. ORIGIO PRODUCT PORTFOLIO
7.17.3. ORIGIO RECENT ACTIVITIES
7.17.4. ORIGIO SWOT ANALYSIS
7.18. OVASCIENCE
7.18.1. COMPANY OVERVIEW
7.18.2. OVASCIENCE PRODUCT PORTFOLIO
7.18.3. OVASCIENCE RECENT ACTIVITIES
7.18.4. OVASCIENCE SWOT ANALYSIS
7.19. PFIZER INC.
7.19.1. COMPANY OVERVIEW
7.19.2. PFIZER INC. PRODUCT PORTFOLIO
7.19.3. PFIZER INC. RECENT ACTIVITIES
7.19.4. PFIZER INC. SWOT ANALYSIS
7.20. PRINCETON BIOMEDITECH CORP.
7.20.1. COMPANY OVERVIEW
7.20.2. PRINCETON BIOMEDITECH CORP. PRODUCT PORTFOLIO
7.20.3. PRINCETON BIOMEDITECH CORP. RECENT ACTIVITIES
7.20.4. PRINCETON BIOMEDITECH CORP. SWOT ANALYSIS
7.21. PROGYNY
7.21.1. COMPANY OVERVIEW
7.21.2. PROGYNY PRODUCT PORTFOLIO
7.21.3. PROGYNY RECENT ACTIVITIES
7.21.4. PROGYNY SWOT ANALYSIS
7.22. QUIDEL CORP
7.22.1. COMPANY OVERVIEW
7.22.2. QUIDEL CORP PRODUCT PORTFOLIO
7.22.3. QUIDEL CORP RECENT ACTIVITIES
7.22.4. QUIDEL CORP SWOT ANALYSIS
7.23. VITROLIFE AB
7.23.1. COMPANY OVERVIEW
7.23.2. VITROLIFE AB PRODUCT PORTFOLIO
7.23.3. VITROLIFE AB RECENT ACTIVITIES
7.23.4. VITROLIFE AB SWOT ANALYSIS
7.24. VIVUS INC.
7.24.1. COMPANY OVERVIEW
7.24.2. VIVUS INC. PRODUCT PORTFOLIO
7.24.3. VIVUS INC. RECENT ACTIVITIES
7.24.4. VIVUS INC. SWOT ANALYSIS
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. SEGMENTATION BY DIAGNOSIS
1.2.2. BY TREATMENT
1.2.3. BY GEOGRAPHY
1.2.4. BY STAKEHOLDERS
1.2.5. EXCEPTIONS
MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. GAP ANALYSIS
2.3. HISTORICAL ANALYSIS
2.4. CURRENT MARKET TRENDS
2.5. ANALYST INSIGHT
2.5.1. KEY FINDINGS
2.5.2. RECOMMENDATION
2.5.3. CONCLUSION
2.6. REGULATION
2.6.1. UNITED STATES
2.6.2. EUROPEAN UNION
2.6.3. CHINA
2.6.4. INDIA
2.6.5. REST OF THE WORLD
MARKET DETERMINANT
3.1. MOTIVATORS
3.1.1. LIFESTYLE FACTOR SUCH AS SMOKING, STRESS AND WEIGHT
3.1.2. FEMALE AGE FACTOR (AGE ABOVE 35 YEARS)
3.1.3. ERECTILE DYSFUNCTION IS ANOTHER FACTOR DRIVING MALE INFERTILITY TREATMENT MARKET
3.1.4. INCREASED SUCCESS RATE OF IVF TREATMENT IS DRIVING THE MARKET
3.1.5. HIGH PREVALENCE RATE IN MALE AND FEMALE BOTH
3.1.6. THE MARKET IS MOTIVATED BY DONOR EGG AND SPERM
3.1.7. SURROGACY IS ANOTHER DRIVING FACTOR OF THE MARKET
3.1.8. JOINT VENTURE AND COLLABORATION TO PROVIDE PROPER MEDICAL CARE
3.1.9. NEW TECHNOLOGIES TO AVOID MULTIPLE EMBRYO IMPLANTS
3.1.10. SURROGACY IS LEGAL IN SOME GEOGRAPHIES
3.2. RESTRAINT
3.2.1. COST STRUCTURE IS A RESTRAINT FOR THE MARKET
3.2.2. LACK OF INFRASTRUCTURE IN DEVELOPING COUNTRIES
3.2.3. REIMBURSEMENT POLICIES IN VARIOUS GEOGRAPHIES ARE RESTRAINING THE MARKET
3.3. OPPORTUNITY
3.3.1. EMERGING MARKET SUCH AS INDIA AND CHINA ARE MOST OPPORTUNITY MARKETS
3.3.2. MEDICAL TOURISM IN DEVELOPING COUNTRIES
MARKET SEGMENTATION
4.1. GLOBAL INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1. MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.1. SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.2. GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.3. TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.4. HORMONE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.1.5. OTHER TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2. FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.1. OVULATION TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.2. HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.3. HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.4. IMAGING TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.5. OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.6. HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.7. GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.1.2.8. OTHERS TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2. GLOBAL INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1. MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.1. DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.2. SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.3. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.1.4. OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2. FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.1. DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.2. SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.3. INTRAUTERINE INSEMINATION (IUI) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4. ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.1. IN VITRO FERTILIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.2. INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.4.3. ASSISTED HATCHING MARKET RESEARCH AND ANALYSIS, 2015-2021
4.2.2.5. OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPETITIVE LANDSCAPE
5.1. MARKET SHARE ANALYSIS
5.2. KEY COMPANY ANALYSIS
5.3. KEY STRATEGIES ANALYSIS
5.3.1. PARTNERSHIP AND COLLABORATION
5.3.2. PRODUCT LAUNCHES AND NEW PRODUCT DEVELOPMENTS
5.3.3. MERGER AND ACQUISITION
5.3.4. PATENT AND LICENSES
5.3.5. OTHER STRATEGIES
REGIONAL ANALYSIS
6.1. NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.1. UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
6.1.2. CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2. EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.1. WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.2.2. ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3. ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.1. INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.2. CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.3. JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
6.3.4. ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
6.4. REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
COMPANY PROFILES
7.1. BAYER AG
7.1.1. COMPANY OVERVIEW
7.1.2. BAYER AG PRODUCT PORTFOLIO
7.1.3. BAYER AG RECENT ACTIVITIES
7.1.4. BAYER AG SWOT ANALYSIS
7.2. BRISTOL-MYERS SQUIBB CO.
7.2.1. COMPANY OVERVIEW
7.2.2. BRISTOL-MYERS SQUIBB CO. PRODUCT PORTFOLIO
7.2.3. BRISTOL-MYERS SQUIBB CO. RECENT ACTIVITIES
7.2.4. BRISTOL-MYERS SQUIBB CO. SWOT ANALYSIS
7.3. CHURCH & DWIGHT COMPANY INC.
7.3.1. COMPANY OVERVIEW
7.3.2. CHURCH & DWIGHT COMPANY INC. PRODUCT PORTFOLIO
7.3.3. CHURCH & DWIGHT COMPANY INC. RECENT ACTIVITIES
7.3.4. CHURCH & DWIGHT COMPANY INC. SWOT ANALYSIS
7.4. COOK MEDICAL, INC.
7.4.1. COMPANY OVERVIEW
7.4.2. COOK MEDICAL, INC. PRODUCT PORTFOLIO
7.4.3. COOK MEDICAL, INC. RECENT ACTIVITIES
7.4.4. COOK MEDICAL, INC. SWOT ANALYSIS
7.5. COOPERSURGICAL INC.
7.5.1. COMPANY OVERVIEW
7.5.2. COOPERSURGICAL INC. PRODUCT PORTFOLIO
7.5.3. COOPERSURGICAL INC. RECENT ACTIVITIES
7.5.4. COOPERSURGICAL INC. SWOT ANALYSIS
7.6. ELI LILLY & CO.
7.6.1. COMPANY OVERVIEW
7.6.2. ELI LILLY & CO. PRODUCT PORTFOLIO
7.6.3. ELI LILLY & CO. RECENT ACTIVITIES
7.6.4. ELI LILLY & CO. SWOT ANALYSIS
7.7. EMD SERONO, INC
7.7.1. COMPANY OVERVIEW
7.7.2. EMD SERONO, INC PRODUCT PORTFOLIO
7.7.3. EMD SERONO, INC RECENT ACTIVITIES
7.7.4. EMD SERONO, INC SWOT ANALYSIS
7.8. ENDO PHARMACEUTICALS INC.
7.8.1. COMPANY OVERVIEW
7.8.2. ENDO PHARMACEUTICALS INC. PRODUCT PORTFOLIO
7.8.3. ENDO PHARMACEUTICALS INC. RECENT ACTIVITIES
7.8.4. ENDO PHARMACEUTICALS INC. SWOT ANALYSIS
7.9. FERRING PHARMACEUTICALS
7.9.1. COMPANY OVERVIEW
7.9.2. FERRING PHARMACEUTICALS PRODUCT PORTFOLIO
7.9.3. FERRING PHARMACEUTICALS RECENT ACTIVITIES
7.9.4. FERRING PHARMACEUTICALS SWOT ANALYSIS
7.10. GENEA
7.10.1. COMPANY OVERVIEW
7.10.2. GENEA PRODUCT PORTFOLIO
7.10.3. GENEA RECENT ACTIVITIES
7.10.4. GENEA SWOT ANALYSIS
7.11. GLAXOSMITHKLINE PLC
7.11.1. COMPANY OVERVIEW
7.11.2. GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
7.11.3. GLAXOSMITHKLINE PLC RECENT ACTIVITIES
7.11.4. GLAXOSMITHKLINE PLC SWOT ANALYSIS
7.12. HALOTECH DNA
7.12.1. COMPANY OVERVIEW
7.12.2. HALOTECH DNA PRODUCT PORTFOLIO
7.12.3. HALOTECH DNA RECENT ACTIVITIES
7.12.4. HALOTECH DNA SWOT ANALYSIS
7.13. IRVINE SCIENTIFIC
7.13.1. COMPANY OVERVIEW
7.13.2. IRVINE SCIENTIFIC PRODUCT PORTFOLIO
7.13.3. IRVINE SCIENTIFIC RECENT ACTIVITIES
7.13.4. IRVINE SCIENTIFIC SWOT ANALYSIS
7.14. JANSSEN PHARMACEUTICAL
7.14.1. COMPANY OVERVIEW
7.14.2. JANSSEN PHARMACEUTICAL PRODUCT PORTFOLIO
7.14.3. JANSSEN PHARMACEUTICAL RECENT ACTIVITIES
7.14.4. JANSSEN PHARMACEUTICAL SWOT ANALYSIS
7.15. MERCK SERONO
7.15.1. COMPANY OVERVIEW
7.15.2. MERCK SERONO PRODUCT PORTFOLIO
7.15.3. MERCK SERONO RECENT ACTIVITIES
7.15.4. MERCK SERONO SWOT ANALYSIS
7.16. NOVARTIS INTERNATIONAL AG
7.16.1. COMPANY OVERVIEW
7.16.2. NOVARTIS INTERNATIONAL AG PRODUCT PORTFOLIO
7.16.3. NOVARTIS INTERNATIONAL AG RECENT ACTIVITIES
7.16.4. NOVARTIS INTERNATIONAL AG SWOT ANALYSIS
7.17. ORIGIO
7.17.1. COMPANY OVERVIEW
7.17.2. ORIGIO PRODUCT PORTFOLIO
7.17.3. ORIGIO RECENT ACTIVITIES
7.17.4. ORIGIO SWOT ANALYSIS
7.18. OVASCIENCE
7.18.1. COMPANY OVERVIEW
7.18.2. OVASCIENCE PRODUCT PORTFOLIO
7.18.3. OVASCIENCE RECENT ACTIVITIES
7.18.4. OVASCIENCE SWOT ANALYSIS
7.19. PFIZER INC.
7.19.1. COMPANY OVERVIEW
7.19.2. PFIZER INC. PRODUCT PORTFOLIO
7.19.3. PFIZER INC. RECENT ACTIVITIES
7.19.4. PFIZER INC. SWOT ANALYSIS
7.20. PRINCETON BIOMEDITECH CORP.
7.20.1. COMPANY OVERVIEW
7.20.2. PRINCETON BIOMEDITECH CORP. PRODUCT PORTFOLIO
7.20.3. PRINCETON BIOMEDITECH CORP. RECENT ACTIVITIES
7.20.4. PRINCETON BIOMEDITECH CORP. SWOT ANALYSIS
7.21. PROGYNY
7.21.1. COMPANY OVERVIEW
7.21.2. PROGYNY PRODUCT PORTFOLIO
7.21.3. PROGYNY RECENT ACTIVITIES
7.21.4. PROGYNY SWOT ANALYSIS
7.22. QUIDEL CORP
7.22.1. COMPANY OVERVIEW
7.22.2. QUIDEL CORP PRODUCT PORTFOLIO
7.22.3. QUIDEL CORP RECENT ACTIVITIES
7.22.4. QUIDEL CORP SWOT ANALYSIS
7.23. VITROLIFE AB
7.23.1. COMPANY OVERVIEW
7.23.2. VITROLIFE AB PRODUCT PORTFOLIO
7.23.3. VITROLIFE AB RECENT ACTIVITIES
7.23.4. VITROLIFE AB SWOT ANALYSIS
7.24. VIVUS INC.
7.24.1. COMPANY OVERVIEW
7.24.2. VIVUS INC. PRODUCT PORTFOLIO
7.24.3. VIVUS INC. RECENT ACTIVITIES
7.24.4. VIVUS INC. SWOT ANALYSIS
LIST OF TABLES
TABLE # 1 INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021.
TABLE # 2 INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 3 GLOBAL INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 4 MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 5 SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 6 GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 7 TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 8 HORMONE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 9 OTHER TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 10 FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 11 OVULATION TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 12 HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 13 HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 14 IMAGING TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 15 OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 16 HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 17 GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 18 OTHERS TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 19 GLOBAL INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 20 MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 21 DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 22 SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 23 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 24 OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 25 FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 26 DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 27 SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 28 INTRAUTERINE INSEMINATION (IUI) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 29 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 30 IN VITRO FERTILIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 31 INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 32 ASSISTED HATCHING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 33 OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 34 NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 35 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 36 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 37 EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 38 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 39 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 40 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 41 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 42 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 43 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 44 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 45 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 46 BAYER AG PRODUCT PORTFOLIO
TABLE # 47 BAYER AG RECENT ACTIVITIES
TABLE # 48 BAYER AG SWOT ANALYSIS
TABLE # 49 BRISTOL-MYERS SQUIBB CO. PRODUCT PORTFOLIO
TABLE # 50 BRISTOL-MYERS SQUIBB CO. RECENT ACTIVITIES
TABLE # 51 BRISTOL-MYERS SQUIBB CO. SWOT ANALYSIS
TABLE # 52 CHURCH & DWIGHT COMPANY INC. PRODUCT PORTFOLIO
TABLE # 53 CHURCH & DWIGHT COMPANY INC. RECENT ACTIVITIES
TABLE # 54 CHURCH & DWIGHT COMPANY INC. SWOT ANALYSIS
TABLE # 55 COOK MEDICAL, INC. PRODUCT PORTFOLIO
TABLE # 56 COOK MEDICAL, INC. RECENT ACTIVITIES
TABLE # 57 COOK MEDICAL, INC. SWOT ANALYSIS
TABLE # 58 COOPERSURGICAL INC. PRODUCT PORTFOLIO
TABLE # 59 COOPERSURGICAL INC. RECENT ACTIVITIES
TABLE # 60 COOPERSURGICAL INC. SWOT ANALYSIS
TABLE # 61 ELI LILLY & CO. PRODUCT PORTFOLIO
TABLE # 62 ELI LILLY & CO. RECENT ACTIVITIES
TABLE # 63 ELI LILLY & CO. SWOT ANALYSIS
TABLE # 64 EMD SERONO, INC PRODUCT PORTFOLIO
TABLE # 65 EMD SERONO, INC RECENT ACTIVITIES
TABLE # 66 EMD SERONO, INC SWOT ANALYSIS
TABLE # 67 ENDO PHARMACEUTICALS INC. PRODUCT PORTFOLIO
TABLE # 68 ENDO PHARMACEUTICALS INC. RECENT ACTIVITIES
TABLE # 69 ENDO PHARMACEUTICALS INC. SWOT ANALYSIS
TABLE # 70 FERRING PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE # 71 FERRING PHARMACEUTICALS RECENT ACTIVITIES
TABLE # 72 FERRING PHARMACEUTICALS SWOT ANALYSIS
TABLE # 73 GENEA PRODUCT PORTFOLIO
TABLE # 74 GENEA RECENT ACTIVITIES
TABLE # 75 GENEA SWOT ANALYSIS
TABLE # 76 GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
TABLE # 77 GLAXOSMITHKLINE PLC RECENT ACTIVITIES
TABLE # 78 GLAXOSMITHKLINE PLC SWOT ANALYSIS
TABLE # 79 HALOTECH DNA PRODUCT PORTFOLIO
TABLE # 80 HALOTECH DNA RECENT ACTIVITIES
TABLE # 81 HALOTECH DNA SWOT ANALYSIS
TABLE # 82 IRVINE SCIENTIFIC PRODUCT PORTFOLIO
TABLE # 83 IRVINE SCIENTIFIC RECENT ACTIVITIES
TABLE # 84 IRVINE SCIENTIFIC SWOT ANALYSIS
TABLE # 85 JANSSEN PHARMACEUTICAL PRODUCT PORTFOLIO
TABLE # 86 JANSSEN PHARMACEUTICAL RECENT ACTIVITIES
TABLE # 87 JANSSEN PHARMACEUTICAL SWOT ANALYSIS
TABLE # 88 MERCK SERONO PRODUCT PORTFOLIO
TABLE # 89 MERCK SERONO RECENT ACTIVITIES
TABLE # 90 MERCK SERONO SWOT ANALYSIS
TABLE # 91 NOVARTIS INTERNATIONAL AG PRODUCT PORTFOLIO
TABLE # 92 NOVARTIS INTERNATIONAL AG RECENT ACTIVITIES
TABLE # 93 NOVARTIS INTERNATIONAL AG SWOT ANALYSIS
TABLE # 94 ORIGIO PRODUCT PORTFOLIO
TABLE # 95 ORIGIO RECENT ACTIVITIES
TABLE # 96 ORIGIO SWOT ANALYSIS
TABLE # 97 OVASCIENCE PRODUCT PORTFOLIO
TABLE # 98 OVASCIENCE RECENT ACTIVITIES
TABLE # 99 OVASCIENCE SWOT ANALYSIS
TABLE # 100 PFIZER INC. PRODUCT PORTFOLIO
TABLE # 101 PFIZER INC. RECENT ACTIVITIES
TABLE # 102 PFIZER INC. SWOT ANALYSIS
TABLE # 103 PRINCETON BIOMEDITECH CORP. PRODUCT PORTFOLIO
TABLE # 104 PRINCETON BIOMEDITECH CORP. RECENT ACTIVITIES
TABLE # 105 PRINCETON BIOMEDITECH CORP. SWOT ANALYSIS
TABLE # 106 PROGYNY PRODUCT PORTFOLIO
TABLE # 107 PROGYNY RECENT ACTIVITIES
TABLE # 108 PROGYNY SWOT ANALYSIS
TABLE # 109 QUIDEL CORP PRODUCT PORTFOLIO
TABLE # 110 QUIDEL CORP RECENT ACTIVITIES
TABLE # 111 QUIDEL CORP SWOT ANALYSIS
TABLE # 112 VITROLIFE AB PRODUCT PORTFOLIO
TABLE # 113 VITROLIFE AB RECENT ACTIVITIES
TABLE # 114 VITROLIFE AB SWOT ANALYSIS
TABLE # 115 VIVUS INC. PRODUCT PORTFOLIO
TABLE # 116 VIVUS INC. RECENT ACTIVITIES
TABLE # 117 VIVUS INC. SWOT ANALYSIS
TABLE # 1 INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021.
TABLE # 2 INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 3 GLOBAL INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 4 MALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 5 SEMEN ANALYSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 6 GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 7 TESTICULAR BIOPSY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 8 HORMONE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 9 OTHER TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 10 FEMALE INFERTILITY DIAGNOSIS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 11 OVULATION TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 12 HYSTEROSALPINGOGRAPHY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 13 HYSTEROSCOPY MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 14 IMAGING TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 15 OVARIAN RESERVE TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 16 HORMONAL LEVEL TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 17 GENETIC TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 18 OTHERS TESTING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 19 GLOBAL INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 20 MALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 21 DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 22 SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 23 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 24 OTHERS MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 25 FEMALE INFERTILITY TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 26 DRUGS AND MEDICINE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 27 SURGICAL MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 28 INTRAUTERINE INSEMINATION (IUI) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 29 ASSISTED REPRODUCTIVE TECHNOLOGY (ART) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 30 IN VITRO FERTILIZATION MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 31 INTRACYTOPLASMIC SPERM INJECTION (ICSI) MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 32 ASSISTED HATCHING MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 33 OTHER MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 34 NORTH AMERICAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 35 UNITED STATES MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 36 CANADA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 37 EUROPEAN INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 38 WESTERN EUROPE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 39 ROE MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 40 ASIA PACIFIC INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 41 INDIA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 42 CHINA MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 43 JAPAN MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 44 ROAPAC MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 45 REST OF THE WORLD INFERTILITY DIAGNOSIS AND TREATMENT MARKET RESEARCH AND ANALYSIS, 2015-2021
TABLE # 46 BAYER AG PRODUCT PORTFOLIO
TABLE # 47 BAYER AG RECENT ACTIVITIES
TABLE # 48 BAYER AG SWOT ANALYSIS
TABLE # 49 BRISTOL-MYERS SQUIBB CO. PRODUCT PORTFOLIO
TABLE # 50 BRISTOL-MYERS SQUIBB CO. RECENT ACTIVITIES
TABLE # 51 BRISTOL-MYERS SQUIBB CO. SWOT ANALYSIS
TABLE # 52 CHURCH & DWIGHT COMPANY INC. PRODUCT PORTFOLIO
TABLE # 53 CHURCH & DWIGHT COMPANY INC. RECENT ACTIVITIES
TABLE # 54 CHURCH & DWIGHT COMPANY INC. SWOT ANALYSIS
TABLE # 55 COOK MEDICAL, INC. PRODUCT PORTFOLIO
TABLE # 56 COOK MEDICAL, INC. RECENT ACTIVITIES
TABLE # 57 COOK MEDICAL, INC. SWOT ANALYSIS
TABLE # 58 COOPERSURGICAL INC. PRODUCT PORTFOLIO
TABLE # 59 COOPERSURGICAL INC. RECENT ACTIVITIES
TABLE # 60 COOPERSURGICAL INC. SWOT ANALYSIS
TABLE # 61 ELI LILLY & CO. PRODUCT PORTFOLIO
TABLE # 62 ELI LILLY & CO. RECENT ACTIVITIES
TABLE # 63 ELI LILLY & CO. SWOT ANALYSIS
TABLE # 64 EMD SERONO, INC PRODUCT PORTFOLIO
TABLE # 65 EMD SERONO, INC RECENT ACTIVITIES
TABLE # 66 EMD SERONO, INC SWOT ANALYSIS
TABLE # 67 ENDO PHARMACEUTICALS INC. PRODUCT PORTFOLIO
TABLE # 68 ENDO PHARMACEUTICALS INC. RECENT ACTIVITIES
TABLE # 69 ENDO PHARMACEUTICALS INC. SWOT ANALYSIS
TABLE # 70 FERRING PHARMACEUTICALS PRODUCT PORTFOLIO
TABLE # 71 FERRING PHARMACEUTICALS RECENT ACTIVITIES
TABLE # 72 FERRING PHARMACEUTICALS SWOT ANALYSIS
TABLE # 73 GENEA PRODUCT PORTFOLIO
TABLE # 74 GENEA RECENT ACTIVITIES
TABLE # 75 GENEA SWOT ANALYSIS
TABLE # 76 GLAXOSMITHKLINE PLC PRODUCT PORTFOLIO
TABLE # 77 GLAXOSMITHKLINE PLC RECENT ACTIVITIES
TABLE # 78 GLAXOSMITHKLINE PLC SWOT ANALYSIS
TABLE # 79 HALOTECH DNA PRODUCT PORTFOLIO
TABLE # 80 HALOTECH DNA RECENT ACTIVITIES
TABLE # 81 HALOTECH DNA SWOT ANALYSIS
TABLE # 82 IRVINE SCIENTIFIC PRODUCT PORTFOLIO
TABLE # 83 IRVINE SCIENTIFIC RECENT ACTIVITIES
TABLE # 84 IRVINE SCIENTIFIC SWOT ANALYSIS
TABLE # 85 JANSSEN PHARMACEUTICAL PRODUCT PORTFOLIO
TABLE # 86 JANSSEN PHARMACEUTICAL RECENT ACTIVITIES
TABLE # 87 JANSSEN PHARMACEUTICAL SWOT ANALYSIS
TABLE # 88 MERCK SERONO PRODUCT PORTFOLIO
TABLE # 89 MERCK SERONO RECENT ACTIVITIES
TABLE # 90 MERCK SERONO SWOT ANALYSIS
TABLE # 91 NOVARTIS INTERNATIONAL AG PRODUCT PORTFOLIO
TABLE # 92 NOVARTIS INTERNATIONAL AG RECENT ACTIVITIES
TABLE # 93 NOVARTIS INTERNATIONAL AG SWOT ANALYSIS
TABLE # 94 ORIGIO PRODUCT PORTFOLIO
TABLE # 95 ORIGIO RECENT ACTIVITIES
TABLE # 96 ORIGIO SWOT ANALYSIS
TABLE # 97 OVASCIENCE PRODUCT PORTFOLIO
TABLE # 98 OVASCIENCE RECENT ACTIVITIES
TABLE # 99 OVASCIENCE SWOT ANALYSIS
TABLE # 100 PFIZER INC. PRODUCT PORTFOLIO
TABLE # 101 PFIZER INC. RECENT ACTIVITIES
TABLE # 102 PFIZER INC. SWOT ANALYSIS
TABLE # 103 PRINCETON BIOMEDITECH CORP. PRODUCT PORTFOLIO
TABLE # 104 PRINCETON BIOMEDITECH CORP. RECENT ACTIVITIES
TABLE # 105 PRINCETON BIOMEDITECH CORP. SWOT ANALYSIS
TABLE # 106 PROGYNY PRODUCT PORTFOLIO
TABLE # 107 PROGYNY RECENT ACTIVITIES
TABLE # 108 PROGYNY SWOT ANALYSIS
TABLE # 109 QUIDEL CORP PRODUCT PORTFOLIO
TABLE # 110 QUIDEL CORP RECENT ACTIVITIES
TABLE # 111 QUIDEL CORP SWOT ANALYSIS
TABLE # 112 VITROLIFE AB PRODUCT PORTFOLIO
TABLE # 113 VITROLIFE AB RECENT ACTIVITIES
TABLE # 114 VITROLIFE AB SWOT ANALYSIS
TABLE # 115 VIVUS INC. PRODUCT PORTFOLIO
TABLE # 116 VIVUS INC. RECENT ACTIVITIES
TABLE # 117 VIVUS INC. SWOT ANALYSIS
LIST OF FIGURES
FIGURE # 1 GAP ANALYSIS
FIGURE # 2 INFERTILITY DIAGNOSIS AND TREATMENT HISTORICAL MARKET ANALYSIS
FIGURE # 3 CURRENT MARKET TREND
FIGURE # 4 FACTOR AFFECTING INFERTILITY DIAGNOSIS AND TREATMENT MARKET 2015 AND 2021
FIGURE # 5 INFERTILITY DIAGNOSIS AND TREATMENT MARKET ANALYSIS 2015 AND 2021
FIGURE # 6 GLOBAL MALE INFERTILITY DIAGNOSIS MARKET 2015 AND 2021
FIGURE # 7 GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET 2015 AND 2021
FIGURE # 8 GLOBAL MALE INFERTILITY TREATMENT MARKET 2015 AND 2021
FIGURE # 9 GLOBAL MALE INFERTILITY TREATMENT MARKET 2015 AND 2021
FIGURE # 10 MARKET SHARE ANALYSIS 2015
FIGURE # 11 NORTH AMERICAN MARKET GROWTH 2015-2021
FIGURE # 12 EUROPEAN MARKET GROWTH 2015-2021
FIGURE # 13 ASIA PACIFIC MARKET GROWTH 2015-2021
FIGURE # 14 REST OF THE WORLD MARKET GROWTH 2015-2021
COMPANIES MENTIONED
1. BAYER AG
2. BRISTOL-MYERS SQUIBB CO.
3. CHURCH & DWIGHT COMPANY INC.
4. COOK MEDICAL, INC.
5. COOPERSURGICAL INC.
6. ELI LILLY & CO.
7. EMD SERONO, INC
8. ENDO PHARMACEUTICALS INC.
9. FERRING PHARMACEUTICALS
10. GENEA
11. GLAXOSMITHKLINE PLC
12. HALOTECH DNA
13. IRVINE SCIENTIFIC
14. JANSSEN PHARMACEUTICAL
15. MERCK SERONO
16. NOVARTIS INTERNATIONAL AG
17. ORIGIO
18. OVASCIENCE
19. PFIZER INC.
20. PRINCETON BIOMEDITECH CORP.
21. PROGYNY
22. QUIDEL CORP
23. VITROLIFE AB
24. VIVUS INC.
FIGURE # 1 GAP ANALYSIS
FIGURE # 2 INFERTILITY DIAGNOSIS AND TREATMENT HISTORICAL MARKET ANALYSIS
FIGURE # 3 CURRENT MARKET TREND
FIGURE # 4 FACTOR AFFECTING INFERTILITY DIAGNOSIS AND TREATMENT MARKET 2015 AND 2021
FIGURE # 5 INFERTILITY DIAGNOSIS AND TREATMENT MARKET ANALYSIS 2015 AND 2021
FIGURE # 6 GLOBAL MALE INFERTILITY DIAGNOSIS MARKET 2015 AND 2021
FIGURE # 7 GLOBAL FEMALE INFERTILITY DIAGNOSIS MARKET 2015 AND 2021
FIGURE # 8 GLOBAL MALE INFERTILITY TREATMENT MARKET 2015 AND 2021
FIGURE # 9 GLOBAL MALE INFERTILITY TREATMENT MARKET 2015 AND 2021
FIGURE # 10 MARKET SHARE ANALYSIS 2015
FIGURE # 11 NORTH AMERICAN MARKET GROWTH 2015-2021
FIGURE # 12 EUROPEAN MARKET GROWTH 2015-2021
FIGURE # 13 ASIA PACIFIC MARKET GROWTH 2015-2021
FIGURE # 14 REST OF THE WORLD MARKET GROWTH 2015-2021
COMPANIES MENTIONED
1. BAYER AG
2. BRISTOL-MYERS SQUIBB CO.
3. CHURCH & DWIGHT COMPANY INC.
4. COOK MEDICAL, INC.
5. COOPERSURGICAL INC.
6. ELI LILLY & CO.
7. EMD SERONO, INC
8. ENDO PHARMACEUTICALS INC.
9. FERRING PHARMACEUTICALS
10. GENEA
11. GLAXOSMITHKLINE PLC
12. HALOTECH DNA
13. IRVINE SCIENTIFIC
14. JANSSEN PHARMACEUTICAL
15. MERCK SERONO
16. NOVARTIS INTERNATIONAL AG
17. ORIGIO
18. OVASCIENCE
19. PFIZER INC.
20. PRINCETON BIOMEDITECH CORP.
21. PROGYNY
22. QUIDEL CORP
23. VITROLIFE AB
24. VIVUS INC.
